The difficult-to-control asthmatic: A systematic approach

Allergy, Asthma and Clinical Immunology

Volumn 2, Issue 3, 2006, Pages 109-116

  Le, Annie V ^a   Simon, Ronald A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; CYCLOSPORIN A; DNA VACCINE; LEUKOTRIENE; OMALIZUMAB; PHENOBARBITAL; PREDNISONE; STEROID; TRIAMCINOLONE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ALLERGIC RHINITIS; ASTHMA; DIAGNOSTIC ACCURACY; DISEASE EXACERBATION; DOSE RESPONSE; GASTROESOPHAGEAL REFLUX; HUMAN; HYPERVENTILATION; LONG TERM CARE; PATIENT COMPLIANCE; PSYCHOLOGICAL ASPECT; REVIEW; SOCIOECONOMICS; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; VOCAL CORD;

EID: 33749161904     PISSN: 17101484     EISSN: None     Source Type: Journal    
DOI: 10.2310/7480.2006.00013     Document Type: Review

References (44)

1. Barnes PJ, Woolcock AJ. Difficult asthma. Eur Respir J 1998;12:1209-18.
2. Sutherland ER, Martin RJ. Airway inflammation in chronic obstructive pulmonary disease: comparisons with asthma. J Allergy Clin Immunol 2003;112:819-27.
3. Sutherland EF. Outpatient treatment of chronic obstructive pulmonary disease: comparisons with asthma. J Allergy Clin Immunol 2004;114:715-24.
4. Thomas PS, Duncan MG, Barnes PJ. Pseudosteroid resistant asthma. Thorax 1999;54:352-6.
5. De Peuter S, Van Diest I, Lemaigre V, et al. Can subjective asthma symptoms be learned? Psychosom Med 2005;67:454-61.
6. O'Connell MA, Sklarew PR, Goodman DL. Spectrum of presentation of paradoxical vocal cord motion in ambulatory patients. Ann Allergy 1995;74:341-4.
7. Christopher KL, Wood RP, Eckert RC, et al. Vocal-cord dysfunction presenting as asthma. N Engl J Med 1983;308:1566-70.
8. Newman KB, Mason UG, Schmaling KB. Clinical features of vocal cord dysfunction. Am J Respir Crit Care Med 1995;152:1382-6.
9. Gavin LA, Wamboldt M, Brugman S. Psychological and family characteristics of adolescents with vocal cord dysfunction. J Asthma 1998;35:409-17.
10. Spector S. Noncompliance with asthma therapy - are there solutions? J Asthma 2000;37:381-8.
11. Celano M, Geller RJ, Philips KM. Treatment adherence among low-income children with asthma. J Pediatr Psychol 1998;23:345-8.
12. Buston KM, Wood SF. Non-compliance amongst adolescents with asthma: listening to what they tell us about self-management. Fam Pract 2000;17:134-8.
13. Daisey JM, Angell WJ, Apte MG. Indoor air quality, ventilation and health symptoms in schools: an analysis of existing information. Indoor Air 2003;13:53-64.
14. Denson-Lino JM, Willies-Jacobo LJ, Rosas A. Effect of economic status on the use of house dust mite avoidance measures in asthmatic children. Ann Allergy 1993;71:130-2.
15. Ind PW, Dixon CMS, Fuller RW. Anticholinergic blockade of β blocker induced bronchoconstriction. Am Rev Respir Dis 1989;139:1390-4.
16. Szczeklik A, Stevenson DD. Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management. J Allergy Clin Immunol 2003;111:913-21.
17. Peroni DG, Boner AL. Sulfite sensitivity. Clin Exp Allergy 1995;25:680-1.
18. Simpson WG. Gastroesophageal reflux disease and asthma: diagnosis and management. Arch Intern Med 1995;155:798-804.
19. Richter JE. Extraesophageal presentations of gastroesophageal reflux disease. Semin Gastroenterol Dis 1997;8:75-89.
20. Park W, Hicks DM, Khandwala F. Laryngopharyngeal reflux: prospective cohort study evaluating optimal dose of proton pump inhibitor therapy and pretherapy predictors of response. Laryngoscope 2005;115:1230-8.
21. Morgan MDL. Dysfunctional breathing in asthma: is it common, identifiable and correctable? Thorax 2002;57:ii31-5.
22. Aubier M, Levy J, Cleici C. Different effects of nasal and bronchial glucocorticoid administration on bronchial hyperresponsiveness in patients with allergic rhinitis. Am Rev Respir Dis 1992;146:122-6.
23. Pongracic J, Evans R III. Environmental and socioeconomic risk factors in asthma. Immunol Allergy Clin North Am 2001;21:413-26.
24. Bindman A, Grumbach K, Osmond D. Preventable hospitalizations and access to health care. JAMA 1995;274:305-11.
25. Evans R. Prevalence, morbidity, and mortality of asthma in the inner city. Pediatr Asthma Allergy Immunol 1994;8:171-7.
26. Togias A, Horowitz E, Joyner D. Evaluating the factors that relate to asthma severity in adolescents. Int Arch Allergy Immunol 1997;113:87-95.
27. Leickly FE, Wade SL, Crain E. Self-reported adherence, management behavior, and barriers to care after an emergency department visit by inner city children with asthma. Pediatrics 1998;101:E8.
28. Strunk R, Mrazek D. Deaths from asthma in childhood: can they be predicted? N Engl Regional Allergy Proc 1986;7:454-61.
29. Kattan M, Mitchell H, Eggleston P. Characteristics of inner-city children with asthma: the National Cooperative Inner-City Asthma Study. Pediatr Pulmonol 1997;24:253-62.
30. Malveaux F, Fletcher-Vincent S. Environmental risk factors of childhood asthma in urban centers. Environ Health Perspect 1995;103 Suppl:59-62.
31. Peden D. The effect of air pollution in asthma and respiratory allergy - the American experience. Allergy Clin Immunol News 1995;7:1-5.
32. Self TH, Chrisman CR, Mason DL, Rumbak MJ. Reducing emergency department visits and hospitalizations in African American and Hispanic patients with asthma: a 15-year review. J Asthma 2005;42:807-12.
33. Rietveld S, Creer TL. Psychiatric factors in asthma: implications for diagnosis and therapy. Am J Respir Med 2003;2:1-10.
34. Beynon HLC, Garbett ND, Barnes PJ. Severe premenstrual exacerbations of asthma: effect of intramuscular progesterone. Lancet 1998;ii:370-2.
35. Ayres JG, Miles JF, Barnes PJ. Brittle asthma. Thorax 1998;53:315-21.
36. Woolcock AJ. Steroid resistant asthma: what is the definition? Eur Respir J 1993;6:743-7.
37. Leung DY, Spahn JD, Szefler SJ. Steroid-unresponsive asthma. Semin Respir Crit Care Med 2002;23:387-98.
38. Ward C, Walters H. Airway wall remodeling: the influence of corticosteroids. Curr Opin Allergy Clin Immunol 2005;5:43-8.
39. ten Brinke A, Zqinderman A, Sterk PJ. "Refractory" eosinophilic airway inflammation in severe asthma. Am J Respir Crit Care Med 2004;170:601-5.
40. Panickar JR, Kenia P, Silverman M. Intramuscular triamcinolone for difficult asthma. Pediatr Pulmonol 2005;39:421-5.
41. Humbert M, Beasley R, Ayres J. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy. Allergy 2005;60:309-16.
42. Berry MA, Hargadon B, Shelley M, et al. Evidence of a role of tumor necrosis factor alpha in refractory asthma. N Engl J Med 2006;354:697-708.
43. Niven AS, Argyros G. Alternate treatments in asthma. Chest 2003;123:1254-65.
44. Varga EM, Noun-Aria-K, Till SJ. Immunomodulatory treatment strategies for allergic diseases. Curr Drugs Targets Inflamm Allergy 2003;2:31-46.